Breaking News Instant updates and real-time market news.

BIOYF

Biosyent

$6.38 /

+0.02 (+0.31%)

12:23
03/10/22
03/10
12:23
03/10/22
12:23

Biosyent price target raised to C$8 from C$7.50 at Raymond James

Raymond James analyst David Novak raised the firm's price target on Biosyent to C$8 from C$7.50 and keeps a Market Perform rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Deere price target raised to $450 from $375 at BMO Capital » 07:07
11/28/22
11/28
07:07
11/28/22
07:07
DE

Deere

$441.27 /

+3.92 (+0.90%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DE Deere
$441.27 /

+3.92 (+0.90%)

DE Deere
$441.27 /

+3.92 (+0.90%)

11/25/22 BofA
Deere price target raised to $478 from $444 at BofA
11/25/22 Morgan Stanley
Deere price target raised to $522 from $424 at Morgan Stanley
11/25/22 Argus
Deere price target raised to $475 from $420 at Argus
11/25/22 JPMorgan
Deere price target raised to $440 from $415 at JPMorgan
DE Deere
$441.27 /

+3.92 (+0.90%)

DE Deere
$441.27 /

+3.92 (+0.90%)

DE Deere
$441.27 /

+3.92 (+0.90%)

DE Deere
$441.27 /

+3.92 (+0.90%)

Hot Stocks
Xortx completes screening, enrollment in Bridging Pharmacokinetics Study » 07:07
11/28/22
11/28
07:07
11/28/22
07:07
XRTX

Xortx Therapeutics

/

+

XORTX Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XRTX Xortx Therapeutics
/

+

XRTX Xortx Therapeutics
/

+

04/22/22 Alliance Global Partners
Xortx Therapeutics price target lowered to $9 from $11 at Alliance Global Partners
12/09/21 Alliance Global Partners
Xortx Therapeutics initiated with a Buy at Alliance Global Partners
Earnings
Anavex reports Q4 EPS (18c), consensus (16c) » 07:06
11/28/22
11/28
07:06
11/28/22
07:06
AVXL

Anavex

$11.87 /

+0.53 (+4.67%)

"This is an exciting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVXL Anavex
$11.87 /

+0.53 (+4.67%)

AVXL Anavex
$11.87 /

+0.53 (+4.67%)

06/23/22 Berenberg
Anavex initiated with a Buy at Berenberg
02/02/22 Cantor Fitzgerald
Anavex price target lowered to $16 from $27 at Cantor Fitzgerald
AVXL Anavex
$11.87 /

+0.53 (+4.67%)

AVXL Anavex
$11.87 /

+0.53 (+4.67%)

Hot Stocks
Sarepta announces FDA grants priority review for SRP-9001 BLA » 07:04
11/28/22
11/28
07:04
11/28/22
07:04
SRPT

Sarepta

$114.52 /

-0.25 (-0.22%)

Sarepta Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$114.52 /

-0.25 (-0.22%)

SRPT Sarepta
$114.52 /

-0.25 (-0.22%)

11/25/22 Oppenheimer
Sarepta 'M&A Buy' thesis may be 'more ripe currently,' says Oppenheimer
11/03/22 Credit Suisse
Sarepta price target raised to $101 from $93 at Credit Suisse
11/03/22 Baird
Sarepta price target raised to $152 from $110 at Baird
10/20/22 JPMorgan
Sarepta added to Analyst Focus List at JPMorgan
SRPT Sarepta
$114.52 /

-0.25 (-0.22%)

SRPT Sarepta
$114.52 /

-0.25 (-0.22%)

Hot Stocks
Singularity Future Technology receives positive Nasdaq listing determination » 07:04
11/28/22
11/28
07:04
11/28/22
07:04
SGLY

Singularity Future Technology

/

+

Singularity Future…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGLY Singularity Future Technology
/

+

SGLY Singularity Future Technology
/

+

Recommendations
Adient price target raised to $29 from $27 at Morgan Stanley » 07:03
11/28/22
11/28
07:03
11/28/22
07:03
ADNT

Adient

$38.98 /

-0.33 (-0.84%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$38.98 /

-0.33 (-0.84%)

ADNT Adient
$38.98 /

-0.33 (-0.84%)

11/08/22 Deutsche Bank
Adient downgraded to Hold from Buy at Deutsche Bank
11/07/22 RBC Capital
Adient cut to Sector Perform at RBC Capital on risk from inflation and demand
11/07/22 Wells Fargo
Adient price target raised to $42 from $37 at Wells Fargo
11/07/22 RBC Capital
Adient downgraded to Sector Perform from Outperform at RBC Capital
ADNT Adient
$38.98 /

-0.33 (-0.84%)

Hot Stocks
Main Street announces new $240M secured credit facility » 07:03
11/28/22
11/28
07:03
11/28/22
07:03
MAIN

Main Street

$38.90 /

+0.47 (+1.22%)

, TFC

Truist Financial

$47.00 /

+0.585 (+1.26%)

Main Street Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAIN Main Street
$38.90 /

+0.47 (+1.22%)

TFC Truist Financial
$47.00 /

+0.585 (+1.26%)

MAIN Main Street
$38.90 /

+0.47 (+1.22%)

08/08/22 Raymond James
Main Street downgraded to Market Perform from Outperform at Raymond James
03/07/22 Hovde Group
Main Street initiated with a Market Perform at Hovde Group
TFC Truist Financial
$47.00 /

+0.585 (+1.26%)

11/02/22 JPMorgan
Truist Financial price target lowered to $47.50 from $48.50 at JPMorgan
10/19/22 RBC Capital
Truist Financial price target lowered to $60 from $70 at RBC Capital
10/19/22 Evercore ISI
Truist Financial downgraded to In Line from Outperform at Evercore ISI
10/11/22 JPMorgan
Truist Financial price target lowered to $48.50 from $56.50 at JPMorgan
MAIN Main Street
$38.90 /

+0.47 (+1.22%)

TFC Truist Financial
$47.00 /

+0.585 (+1.26%)

  • 11
    Aug
TFC Truist Financial
$47.00 /

+0.585 (+1.26%)

TFC Truist Financial
$47.00 /

+0.585 (+1.26%)

Hot Stocks
Builders FirstSource board authorizes $1B increase to stock repurchase plan » 07:02
11/28/22
11/28
07:02
11/28/22
07:02
BLDR

Builders FirstSource

$60.74 /

+0.29 (+0.48%)

Builders FirstSource…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

11/17/22 Baird
Builders FirstSource price target lowered to $80 from $84 at Baird
11/11/22 Deutsche Bank
Builders FirstSource price target lowered to $72 from $85 at Deutsche Bank
11/09/22 Wedbush
Builders FirstSource price target lowered to $80 from $110 at Wedbush
11/09/22 DA Davidson
Builders FirstSource cut to Neutral at DA Davidson amid sputtering homebuilding
BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

Hot Stocks
Aircastle announces retirement of Chief Technical Officer Schreiner » 07:01
11/28/22
11/28
07:01
11/28/22
07:01
AYR

Aircastle

$32.00 /

+ (+0.00%)

Aircastle announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AYR Aircastle
$32.00 /

+ (+0.00%)

Recommendations
Take-Two price target lowered to $145 from $150 at Morgan Stanley » 07:00
11/28/22
11/28
07:00
11/28/22
07:00
TTWO

Take-Two

$102.70 /

-0.46 (-0.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

11/17/22 Truist
Take-Two price target lowered to $131 from $157 at Truist
11/16/22 Truist
Take-Two price target lowered to $131 from $157 at Truist
11/10/22 DZ Bank
Take-Two upgraded to Buy from Hold at DZ Bank
11/08/22 BofA
BofA upgrades 'cheap enough' Take-Two to Buy
TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

TTWO Take-Two
$102.70 /

-0.46 (-0.45%)

Hot Stocks
Aimco expands commitment to governance enhancements » 06:59
11/28/22
11/28
06:59
11/28/22
06:59
AIV

Aimco

$8.21 /

+0.115 (+1.42%)

Apartment Investment and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIV Aimco
$8.21 /

+0.115 (+1.42%)

AIV Aimco
$8.21 /

+0.115 (+1.42%)

AIV Aimco
$8.21 /

+0.115 (+1.42%)

Downgrade
Playtika downgraded to Equal Weight from Overweight at Morgan Stanley » 06:58
11/28/22
11/28
06:58
11/28/22
06:58
PLTK

Playtika

$9.33 /

-0.13 (-1.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTK Playtika
$9.33 /

-0.13 (-1.37%)

PLTK Playtika
$9.33 /

-0.13 (-1.37%)

11/09/22 Wedbush
Playtika price target lowered to $15 from $20 at Wedbush
11/09/22 Macquarie
Playtika price target lowered to $18 from $20 at Macquarie
10/12/22 BTIG
Playtika downgraded to Neutral from Buy at BTIG
08/23/22 BofA
Playtika resumed with an Underperform at BofA
PLTK Playtika
$9.33 /

-0.13 (-1.37%)

PLTK Playtika
$9.33 /

-0.13 (-1.37%)

PLTK Playtika
$9.33 /

-0.13 (-1.37%)

PLTK Playtika
$9.33 /

-0.13 (-1.37%)

Upgrade
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target » 06:57
11/28/22
11/28
06:57
11/28/22
06:57
ATVI

Activision Blizzard

$73.37 /

-3.195 (-4.17%)

, MSFT

Microsoft

$247.54 /

-0.12 (-0.05%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

06:53 Today Morgan Stanley
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley
06:13 Today Truist
Activision Blizzard upgraded to Buy from Hold at Truist
05:23 Today Wells Fargo
Activision Blizzard upgraded to Overweight from Equal Weight at Wells Fargo
11/22/22 Baird
Activision Blizzard upgraded to Outperform from Neutral at Baird
MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

06:53 Today Morgan Stanley
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley
06:13 Today Truist
Activision Blizzard upgraded to Buy from Hold at Truist
11/22/22 Baird
Activision Blizzard upgraded to Outperform from Neutral at Baird
11/16/22 Deutsche Bank
Activision Blizzard price target lowered to $83 from $84 at Deutsche Bank
ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

Initiation
Unity resumed with an Equal Weight at Morgan Stanley » 06:56
11/28/22
11/28
06:56
11/28/22
06:56
U

Unity

$35.64 /

-0.5 (-1.38%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
U Unity
$35.64 /

-0.5 (-1.38%)

U Unity
$35.64 /

-0.5 (-1.38%)

11/21/22 Citi
Unity price target lowered to $54 from $61 at Citi
11/17/22 Stifel
Unity price target raised to $40 from $30 at Stifel
11/15/22 Goldman Sachs
Unity reinstated with a Neutral at Goldman Sachs
11/10/22 DA Davidson
Unity price target lowered to $40 from $60 at DA Davidson
U Unity
$35.64 /

-0.5 (-1.38%)

U Unity
$35.64 /

-0.5 (-1.38%)

U Unity
$35.64 /

-0.5 (-1.38%)

U Unity
$35.64 /

-0.5 (-1.38%)

Hot Stocks
Immuneering doses first patient in Phase 1/2a trial of IMM-1-104 » 06:55
11/28/22
11/28
06:55
11/28/22
06:55
IMRX

Immuneering

$6.50 /

+0.23 (+3.67%)

Immuneering Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMRX Immuneering
$6.50 /

+0.23 (+3.67%)

IMRX Immuneering
$6.50 /

+0.23 (+3.67%)

09/30/22 Piper Sandler
Immuneering transitions to clinical stage with IND approval, says Piper Sandler
07/25/22 Piper Sandler
Immuneering CFO departure not a 'red flag,' says Piper Sandler
07/08/22 Chardan
Immuneering initiated with a Buy at Chardan
03/31/22 Oppenheimer
Immuneering initiated with an Outperform at Oppenheimer
IMRX Immuneering
$6.50 /

+0.23 (+3.67%)

Initiation
Xenon Pharmaceuticals initiated with an Overweight at Wells Fargo » 06:55
11/28/22
11/28
06:55
11/28/22
06:55
XENE

Xenon Pharmaceuticals

$34.77 /

+0.36 (+1.05%)

Wells Fargo analyst Mohit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.77 /

+0.36 (+1.05%)

XENE Xenon Pharmaceuticals
$34.77 /

+0.36 (+1.05%)

10/18/22 Raymond James
Raymond James starts 'rare opportunity' Xenon with Outperform
10/18/22 Raymond James
Xenon Pharmaceuticals initiated with an Outperform at Raymond James
10/11/22 RBC Capital
Xenon Pharmaceuticals price target raised to $49 from $46 at RBC Capital
08/29/22 BofA
BofA starts Xenon Pharma at Buy, sees '1101 as 'uniquely differentiated'
XENE Xenon Pharmaceuticals
$34.77 /

+0.36 (+1.05%)

  • 23
    Jun
XENE Xenon Pharmaceuticals
$34.77 /

+0.36 (+1.05%)

Downgrade
AppLovin downgraded to Equal Weight from Overweight at Morgan Stanley » 06:54
11/28/22
11/28
06:54
11/28/22
06:54
APP

AppLovin

$14.03 /

-0.05 (-0.36%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APP AppLovin
$14.03 /

-0.05 (-0.36%)

APP AppLovin
$14.03 /

-0.05 (-0.36%)

11/22/22 Citi
AppLovin price target lowered to $34 from $60 at Citi
11/17/22 JPMorgan
AppLovin reinstated with Neutral from Overweight at JPMorgan
11/11/22 BofA
AppLovin downgraded to Neutral from Buy at BofA
11/10/22 Credit Suisse
AppLovin price target lowered to $57 from $63 at Credit Suisse
APP AppLovin
$14.03 /

-0.05 (-0.36%)

  • 03
    Dec
APP AppLovin
$14.03 /

-0.05 (-0.36%)

APP AppLovin
$14.03 /

-0.05 (-0.36%)

APP AppLovin
$14.03 /

-0.05 (-0.36%)

Hot Stocks
US Foods appoints Dave Flitman as CEO » 06:53
11/28/22
11/28
06:53
11/28/22
06:53
USFD

US Foods

$35.92 /

-0.04 (-0.11%)

, BLDR

Builders FirstSource

$60.74 /

+0.29 (+0.48%)

US Foods Holding (USFD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USFD US Foods
$35.92 /

-0.04 (-0.11%)

BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

USFD US Foods
$35.92 /

-0.04 (-0.11%)

11/11/22 Deutsche Bank
US Foods price target lowered to $41 from $44 at Deutsche Bank
10/20/22 Barclays
US Foods price target lowered to $31 from $36 at Barclays
10/05/22 Piper Sandler
US Foods price target lowered to $36 from $46 at Piper Sandler
09/07/22 JPMorgan
US Foods reinstated with a Neutral at JPMorgan
BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

11/17/22 Baird
Builders FirstSource price target lowered to $80 from $84 at Baird
11/11/22 Deutsche Bank
Builders FirstSource price target lowered to $72 from $85 at Deutsche Bank
11/09/22 Wedbush
Builders FirstSource price target lowered to $80 from $110 at Wedbush
11/09/22 DA Davidson
Builders FirstSource cut to Neutral at DA Davidson amid sputtering homebuilding
USFD US Foods
$35.92 /

-0.04 (-0.11%)

BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

USFD US Foods
$35.92 /

-0.04 (-0.11%)

USFD US Foods
$35.92 /

-0.04 (-0.11%)

BLDR Builders FirstSource
$60.74 /

+0.29 (+0.48%)

Initiation
Halozyme initiated with an Overweight at Wells Fargo » 06:53
11/28/22
11/28
06:53
11/28/22
06:53
HALO

Halozyme

/

+

Wells Fargo analyst Mohit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
/

+

HALO Halozyme
/

+

09/09/22 Morgan Stanley
Halozyme initiated with an Overweight at Morgan Stanley
08/10/22 Benchmark
Halozyme recent weakness a buying opportunity, says Benchmark
05/23/22 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
04/14/22 Truist
Antares Pharma downgraded to Hold from Buy at Truist
HALO Halozyme
/

+

HALO Halozyme
/

+

Downgrade
Wells Fargo downgrades TransDigm to Equal Weight, lowers price target to $660 » 06:53
11/28/22
11/28
06:53
11/28/22
06:53
TDG

TransDigm

$636.17 /

-2.83 (-0.44%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDG TransDigm
$636.17 /

-2.83 (-0.44%)

TDG TransDigm
$636.17 /

-2.83 (-0.44%)

05:21 Today Wells Fargo
TransDigm downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Credit Suisse
TransDigm price target raised to $718 from $661 at Credit Suisse
11/09/22 JPMorgan
TransDigm price target lowered to $700 from $705 at JPMorgan
10/11/22 Credit Suisse
TransDigm initiated with Outperform on consistent growth at Credit Suisse
TDG TransDigm
$636.17 /

-2.83 (-0.44%)

Upgrade
Activision Blizzard upgraded to Overweight from Equal Weight at Morgan Stanley » 06:53
11/28/22
11/28
06:53
11/28/22
06:53
ATVI

Activision Blizzard

$73.37 /

-3.195 (-4.17%)

, MSFT

Microsoft

$247.54 /

-0.12 (-0.05%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

06:13 Today Truist
Activision Blizzard upgraded to Buy from Hold at Truist
05:23 Today Wells Fargo
Activision Blizzard upgraded to Overweight from Equal Weight at Wells Fargo
11/22/22 Baird
Activision Blizzard upgraded to Outperform from Neutral at Baird
11/16/22 Deutsche Bank
Activision Blizzard price target lowered to $83 from $84 at Deutsche Bank
MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

06:13 Today Truist
Activision Blizzard upgraded to Buy from Hold at Truist
11/22/22 Baird
Activision Blizzard upgraded to Outperform from Neutral at Baird
11/16/22 Deutsche Bank
Activision Blizzard price target lowered to $83 from $84 at Deutsche Bank
11/15/22 MKM Partners
MKM upgrades Activision Blizzard to Buy, sees stock discount growth potential
ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

ATVI Activision Blizzard
$73.37 /

-3.195 (-4.17%)

MSFT Microsoft
$247.54 /

-0.12 (-0.05%)

Hot Stocks
ANI Pharmaceuticals receives FDA approval for ANDA for Fluoxetine Oral Solution » 06:51
11/28/22
11/28
06:51
11/28/22
06:51
ANIP

ANI Pharmaceuticals

$41.43 /

+1.03 (+2.55%)

ANI Pharmaceuticals,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANIP ANI Pharmaceuticals
$41.43 /

+1.03 (+2.55%)

ANIP ANI Pharmaceuticals
$41.43 /

+1.03 (+2.55%)

09/07/22 H.C. Wainwright
ANI Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/16/22 Raymond James
ANI Pharmaceuticals price target lowered to $47 from $65 at Raymond James
ANIP ANI Pharmaceuticals
$41.43 /

+1.03 (+2.55%)

Hot Stocks
National Energy Services secures directional drilling services contract » 06:49
11/28/22
11/28
06:49
11/28/22
06:49
NESR

National Energy Services

$6.36 /

+0.08 (+1.27%)

National Energy Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NESR National Energy Services
$6.36 /

+0.08 (+1.27%)

NESR National Energy Services
$6.36 /

+0.08 (+1.27%)

04/24/22 National Bank
National Energy downgraded to Sector Perform from Outperform at National Bank
Hot Stocks
OneSpaWorld enters seven-year contract with Norwegian Cruise Line » 06:48
11/28/22
11/28
06:48
11/28/22
06:48
OSW

OneSpaWorld

$10.14 /

+0.14 (+1.40%)

, NCLH

Norwegian Cruise Line

$16.45 /

+0.125 (+0.77%)

OneSpaWorld Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSW OneSpaWorld
$10.14 /

+0.14 (+1.40%)

NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

OSW OneSpaWorld
$10.14 /

+0.14 (+1.40%)

11/01/22 Truist
Truist starts OneSpaWorld with Buy into excess free cash flow
11/01/22 Truist
OneSpaWorld initiated with a Buy at Truist
NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

11/22/22 Truist
Norwegian Cruise Line price target raised to $21 from $19 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Norwegian Cruise Line price target raised to $24 from $15 at UBS
11/11/22 Deutsche Bank
Norwegian Cruise Line price target lowered to $14 from $16 at Deutsche Bank
OSW OneSpaWorld
$10.14 /

+0.14 (+1.40%)

NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

NCLH Norwegian Cruise Line
$16.45 /

+0.125 (+0.77%)

Recommendations
Intuit price target lowered to $450 from $525 at KeyBanc » 06:47
11/28/22
11/28
06:47
11/28/22
06:47
INTU

Intuit

$394.07 /

-1.68 (-0.42%)

KeyBanc analyst Josh Beck…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$394.07 /

-1.68 (-0.42%)

INTU Intuit
$394.07 /

-1.68 (-0.42%)

11/21/22 Credit Suisse
Intuit initiated with an Outperform at Credit Suisse
11/21/22 BMO Capital
Intuit price target lowered to $467 from $533 at BMO Capital
11/18/22 Barclays
Intuit price target lowered to $490 from $502 at Barclays
11/02/22 Morgan Stanley
Intuit commitment to defending profit 'should be rewarded,' says Morgan Stanley
INTU Intuit
$394.07 /

-1.68 (-0.42%)

  • 30
    Nov
INTU Intuit
$394.07 /

-1.68 (-0.42%)

INTU Intuit
$394.07 /

-1.68 (-0.42%)

INTU Intuit
$394.07 /

-1.68 (-0.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.